6640--CBOC Point of Care Testing Cost per test Brand Name or Equal

The Department of Veterans Affairs Veterans Integrated Service Network 12 seeks FDA-approved or FDA-authorized, CLIA-waived point-of-care respiratory virus testing systems, with proposals due June 5. This is an unrestricted, firm-fixed-price IDIQ with a minimum guarantee of $115,000 and ceiling of $800,000 over the contract life.

Place of performance is six CBOC locations across Illinois: Peoria, Bloomington, Springfield, Decatur, Mattoon, and Champaign. The systems must perform simultaneous detection of SARS-CoV-2, RSV, Influenza A & B, and Strep A from nasal swab specimens, deliver results within approximately 30 minutes, be CLIA-waived, and interface with VA RALS middleware and VistA/CPRS. All costs must be inclusive of analyzers, reagents, supplies, maintenance, quality control, training, validation, 24/7 technical support, and overnight replacement of malfunctioning units. Delivery and installation must occur within 30 days of award.

The contract runs August 1, 2026 through July 31, 2027 (base year) plus four one-year option periods. Pricing is cost per test on a reagent rental basis, with quantities of six instruments, 1,680 SARS-CoV-2/Flu A&B/RSV tests annually, 140 Strep A tests annually, and quality control supplies per year across all ordering periods. Systems must meet Roche LAIT salient characteristics or equivalent. Evaluation weighs technical capability and price as best overall value; all quotes must meet minimum standards and comply with Buy American requirements. The NAICS code is 334516, Analytical Laboratory Instrument Manufacturing; PSC is 6640.